TA B L E 1
Trends in the number of registered initiated cycles, egg retrievals, pregnancies, and neonates according to IVF, ICSI, and frozen-thawed ET cycles in Japan, 1985 and launched an online registration system in 2007. Since then, cycle-specific information for all ART treatment cycles performed in ART facilities has been collected. The aim of the present report was to describe the characteristics and treatment outcomes of registered ART cycles during 2017 in comparison with previous year. 2 
| MATERIAL S AND ME THODS
Since 2007, the JSOG has requested all participating ART clinics and hospitals to register cycle-specific information for all ART treatment cycles. The information includes patient characteristics, information on ART treatment, and pregnancy and obstetric outcomes. Detailed information collected in the registry has been reported previously. Treatment outcomes included pregnancy, miscarriage and live birth rates, multiple pregnancies, pregnancy outcomes for ectopic pregnancy, intrauterine pregnancy coexisting with an ectopic pregnancy, artificial abortion, stillbirth, and fetal reduction. Furthermore, the treatment outcomes of pregnancy, live birth, miscarriage, and multiple pregnancy rates were analyzed according to patient age. We also described treatment outcomes for cycles using frozen-thawed oocytes based on medical indications. Including cycles using frozen-thawed oocytes. Single ET was performed at a rate of 83.5%, and the singleton pregnancy and live birth rates were 96.7% and 96.6%, respectively.
| RE SULTS
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Treatment outcomes of registered cycles, including pregnancy, miscarriage, live birth, and multiple pregnancy rates, according to patient age, are shown in Table 4 . Similarly, the distribution of pregnancy, live birth, and miscarriage rates according to patient age are shown in Figure 2 . The pregnancy rate per ET exceeded 40% up to 35 years of age; this rate gradually fell below 30% after age 39 years and below 10% after age 45 years. The miscarriage rate was below 20% under age 35 years but gradually increased to 33.6% and 49.3%
for those aged 40 and 43 years, respectively. The live birth rate per registered cycle was around 20% up to 33 years of age and decreased to 9.3% and 3.1% at ages 40 and 43 years, respectively. Multiple pregnancy rates varied between 2% and 3% across most age groups.
The treatment outcomes of cycles using frozen-thawed oocytes based on medical indications are shown in Table 5 . There were a total of 91 cycles using frozen oocytes, among which 21 cycles resulted in pregnancy (pregnancy rate per FET = 23.1%). The miscarriage rate per pregnancy was 14.3%, resulting in a 19.8% live birth rate per ET. a significantly higher live birth rate than did fresh blastocyst ET (RR = 1.26, 95% CI, 1.14 to 1.41). 6 Thus, evidence for the use of a freeze-all strategy in the entire IVF population remains limited.
| D ISCUSS I ON
FET might increase specific complications during pregnancy.
Previous analysis using the Japanese ART registry has demonstrated that FET is associated with significantly higher risk for hypertensive disorders of pregnancy (HDP) and placenta accreta than fresh ET. 7 In particular, higher risk of HDP in FET is noted in several RCTs. 4, 6 Recently, it was reported that methods of endometrium preparation, especially hormone replacement cycles for FET, might be associated with these complications. 8 Therefore, caution should be exerted with respect to the risks of specific pregnancy complications, although frozen ET is reported to be beneficial in avoiding OHSS and reducing the risk of low birth weight and preterm delivery, as compared with fresh cycles. 9 ICSI cycles accounted for 63% of registered fresh cycles in 2017.
An increasing trend in ICSI use is seen worldwide. 
Society for Reproductive Medicine and the Society for Assisted
Reproductive Technology have concluded that routine use of ICSI in patients with non-male factor infertility is not recommended. 13 The strength of the Japanese ART registry is its mandatory reporting system with a high compliance rate, in cooperation with the government subsidy system. Using this system, nearly all participating ART facilities (606 of 607 facilities) have registered cycle-specific information.
Nevertheless, several limitations exist in the registry. First, the registry includes only cycle-specific information; it is very difficult to identify cycles in the same patient using the registry. Under current Japanese ART practice, in which nearly half of initiated cycles are freeze-all, current indicators such as pregnancy and live birth rate per aspiration cycle would be markedly underestimated. In fact, the abovementioned report from ICMART described that the delivery rate per oocyte aspiration in Japan was the lowest among 65 countries, which could mislead public opinion regarding the quality of treatment as ET was not performed in most included fresh cycles. 1 It has recently been suggested that the cumulative live birth rate per oocyte aspiration is more suitable when reporting the success rate of IVF outcomes. 14, 15 Yet, the appropriate definitions to be used in calculating the cumulative live birth rate are under discussion. The format of the Japanese ART registry may need to be changed, to report indicators for comparability.
Second, the Japanese ART registry includes unfertilized oocyte freezing cycles only for medically indicated cases, such as fertility preservation in cancer patients; the registry does not include cycles with non-medical indications. Because no other regulatory measure in reproductive medicine that includes oocyte freezing is enforced in Japan, there is no information available regarding the practices outside this registry.
In conclusion, our analysis of the ART registry during 2017 demonstrated that the total number of ART cycles increased whereas the number of initiated fresh cycles decreased for the first time ever. SET was performed at a rate of more than 80%, resulting in a 97% singleton live birth rate. Although an increasing trend for frozen ET and freeze-all cycles is characteristic in Japan, further investigation is required to evaluate the effect of the freeze-all strategy and frozen ET on cumulative live births, and particularly with respect to both maternal and neonatal safety issues. These data represent the latest clinical practices of ART in Japan. Further improvement in the ART registration system in Japan is important.
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